Cimetidine: Difference between revisions

(Text replacement - "0 mg" to "0mg")
No edit summary
Line 5: Line 5:


==Adult Dosing==
==Adult Dosing==
===Duodenal Ulcer, Active===
*800mg PO QHS x 4-8 weeks


Duodenal Ulcer, Active: 800mg PO QHS x 4-8 weeks
===Duodenal Ulcer, Maintenance===
*400mg PO QHS


Duodenal Ulcer, Maintenance: 400mg PO QHS
===Gastric Ulcer, active benign===
*800mg PO QHS x 6 weeks


Gastric Ulcer, active benign: 800mg PO QHS x 6 weeks
===H. Pylori Infection===
 
*400mg PO BID x 10-28 days
H. Pylori Infection: 400mg PO BID x 10-28 days


==Pediatric Dosing==
==Pediatric Dosing==
 
===GERD/PUD===
 
*Neonates: 5- 10mg/kg/day PO divided q8-12h
GERD/PUD:
*Infants: 10-20mg/kg/day PO divided q8-12h
    *Neonates: 5- 10mg/kg/day PO divided q8-12h
*Children: 20-40mg/kg/day PO divided q6H
    *Infants: 10-20mg/kg/day PO divided q8-12h
    *Children: 20-40mg/kg/day PO divided q6H


==Special Populations==
==Special Populations==
Line 34: Line 35:
==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
- caution if renal impairment
*caution if renal impairment
- caution if hepatic impairment
*caution if hepatic impairment
- caution in elderly patients
*caution in elderly patients
- caution if chronic pulmonary disease
*caution if chronic pulmonary disease
- caution if DM
*caution if [[DM]]
- caution if immunocompromised
*caution if immunocompromised


==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
- neutropenia
*[[Anticholinergic toxicity]]
- thrombocytopenia
*[[neutropenia]]
- agranulocytosis
*[[thrombocytopenia]]
- aplastic anemia
*agranulocytosis
- pneumonia
*aplastic anemia
-depression
*[[pneumonia]]
-psychosis
*[[depression]]
-hallucinations
*[[psychosis]]
-pancreatitis
*[[hallucinations]]
-interstital nephritis
*[[pancreatitis]]
-bradycardia
*interstital nephritis
-tachycardia
*[[bradycardia]]
-AV block
*[[tachycardia]]
- skin reaction
*[[AV block]]
* skin reaction


===Common===
===Common===
-headche
*[[headche]]
-diarrhea
*[[diarrhea]]
-dizziness
*[[dizziness]]
-gynecomastia
*gynecomastia
-nausea
*[[nausea]]
-vomiting
*[[vomiting]]
-confusion
*confusion
-agitation
*agitation
-drowsiness
*drowsiness
-rash
*[[rash]]
-ALT,AST elevation
*ALT,AST elevation


==Pharmacology==
==Pharmacology==
Line 78: Line 80:


==See Also==
==See Also==
*[[Anticholinergic toxicity]]


==References==
==References==

Revision as of 20:50, 22 January 2017

General

  • Type: H2 blocker
  • Dosage Forms: 200, 300, 400, 800mg
  • Common Trade Names: Tagamet HB 200

Adult Dosing

Duodenal Ulcer, Active

  • 800mg PO QHS x 4-8 weeks

Duodenal Ulcer, Maintenance

  • 400mg PO QHS

Gastric Ulcer, active benign

  • 800mg PO QHS x 6 weeks

H. Pylori Infection

  • 400mg PO BID x 10-28 days

Pediatric Dosing

GERD/PUD

  • Neonates: 5- 10mg/kg/day PO divided q8-12h
  • Infants: 10-20mg/kg/day PO divided q8-12h
  • Children: 20-40mg/kg/day PO divided q6H

Special Populations

  • Pregnancy Rating: B (animal studies show no risk for adverse fetal effects, human fetal harm possible but unlikely)
  • Lactation: Probably Safe
  • Renal Dosing
    • Adult: CrCL 10-50: decrease dose 50%, CrCl <10, decrease dose 75%
    • Pediatric: CrCl 20-40, decrease dose 25% or give q8h, CrCL <20: decrease dose 50%
  • Hepatic Dosing
    • Adult: Not Defined
    • Pediatric not defined

Contraindications

  • Allergy to class/drug
  • caution if renal impairment
  • caution if hepatic impairment
  • caution in elderly patients
  • caution if chronic pulmonary disease
  • caution if DM
  • caution if immunocompromised

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 2H
  • Metabolism: Liver; CYP450, 1A2, 2C19, 2D6 Inhibitor
  • Excretion: urine
  • Mechanism of Action: Histamine H2 Receptor blocker

See Also

References